“A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS”. 2022. Journal of Pharmaceutical Negative Results, September, 972-79. https://doi.org/10.47750/pnr.2022.13.S01.116.